BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Takako Inoue, Yasuhito Tanaka. Novel biomarkers for the management of chronic hepatitis BClinical and Molecular Hepatology 2020; 26(3): 261 doi: 10.3350/cmh.2020.0032
2
Misu Lee, Haeyong Ko, Mijin Yun. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular CarcinomaYonsei Medical Journal 2018; 59(10): 1143 doi: 10.3349/ymj.2018.59.10.1143
3
Ganesan Raja, Haripriya Gupta, Yoseph Asmelash Gebru, Gi Soo Youn, Ye Rin Choi, Hyeong Seop Kim, Sang Jun Yoon, Dong Joon Kim, Tae-Jin Kim, Ki Tae Suk. Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and ApplicationsInternational Journal of Molecular Sciences 2021; 22(3): 1160 doi: 10.3390/ijms22031160
4
David J. Pinato, Alessia Dalla Pria, Rohini Sharma, Mark Bower. Hepatocellular carcinomaAIDS 2017; 31(5): 603 doi: 10.1097/QAD.0000000000001422
5
Yigan Zhang, Huaze Xi, Xin Nie, Peng Zhang, Ning Lan, Ying Lu, Jinrong Liu, Wenzhen Yuan. Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver DiseasesCurrent Drug Metabolism 2019; 20(10): 785 doi: 10.2174/1389200220666191011120434
6
Chunmeng Wei, Yasi Li, Kaiming Huang, Gang Li, Min He. Exosomal miR-1246 in body fluids is a potential biomarker for gastrointestinal cancerBiomarkers in Medicine 2018; 12(10): 1185 doi: 10.2217/bmm-2017-0440
7
Chansik An, Do Young Kim, Jin-Young Choi, Kwang Hyub Han, Yun Ho Roh, Myeong-Jin Kim. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trialBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4827-2
8
Ismail Shah, Sajjad Ali Khan, Sadiq Hussain, Fazlullah Khan, Kamal Niaz. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases2021; : 105 doi: 10.1016/B978-0-12-816488-4.00004-8
9
Fatemeh Nouri Rouz, Mohammad Shirkhoda, Feridon Memari, Hassan Dana, Ghanbar Mahmoodi C, Habibollah Mahmoodzad, Nasim Samarghand, Elahe Gharagozlo, Mohammad Hosein Mohammadi , Ali Reza Maleki, Ehsan Sadeghian, ElhamZainali Nia, Nedazainali Nia, Farimah Hadjilooei, Omid Rezaeian, Saeed Meghdadi, SeyedRohollah Miri, Fatameh Jafari, Elham Rayzan, Vahid Marmari. Immunotherapy a New Hope for Cancer Treatment: A ReviewPakistan Journal of Biological Sciences 2018; 21(3): 135 doi: 10.3923/pjbs.2018.135.150
10
Aly O. Aboelfotoh, Enas M. Foda, Ahmed M. Elghandour, Nahla M. Teama, Reham A. Abouzein, Ghada A. Mohamed. Talin-1; other than a potential marker for hepatocellular carcinoma diagnosisArab Journal of Gastroenterology 2020; 21(2): 80 doi: 10.1016/j.ajg.2020.04.017
11
Taya Kitiyakara, Susan Redmond, Nattawut Unwanatham, Sasivimol Rattanasiri, Amarin Thakkinstian, Pongsatorn Tangtawee, Somkit Mingphruedhi, Abhasnee Sobhonslidsuk, Pongphob Intaraprasong, Chomsri Kositchaiwat. The detection of hepatocellular carcinoma (HCC) from patients’ breath using canine scent detection: a proof-of-concept studyJournal of Breath Research 2017; 11(4): 046002 doi: 10.1088/1752-7163/aa7b8e
12
Guillermo Aquino-Jarquin. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer ResearchCancer Research 2017; 77(24): 6812 doi: 10.1158/0008-5472.CAN-17-2142
13
Carolin Czauderna, Irene Schmidtmann, Sandra Koch, Lukas Pilz, Sophia Heinrich, Gerd Otto, Jens Mittler, Hauke Lang, Roman Kloeckner, Christoph Düber, Martin F Sprinzl, Marcus A Wörns, Peter R Galle, Jens U Marquardt, Arndt Weinmann. High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaUnited European Gastroenterology Journal 2020; : 205064062097261 doi: 10.1177/2050640620972611
14
Hsiao-Chen Tu, Yung-Chun Hsiao, Wan-Yu Yang, Shin-Lin Tsai, Hua-Kuo Lin, Chong-Yi Liao, Jeng-Wei Lu, Yu-Ting Chou, Horng-Dar Wang, Chiou-Hwa Yuh. Up-regulation of golgi α-mannosidase IA and down-regulation of golgi α-mannosidase IC activates unfolded protein response during hepatocarcinogenesisHepatology Communications 2017; 1(3): 230 doi: 10.1002/hep4.1032
15
Chia-Jui Yen, Yu-Lin Ai, Hung-Wen Tsai, Shih-Huang Chan, Chia-Sheng Yen, Kuang-Hsiung Cheng, Yun-Ping Lee, Chia-Wei Kao, Yu-Chun Wang, Yi-Lin Chen, Cheng-Han Lin, Tsunglin Liu, Huey-Pin Tsai, Jen-Ren Wang, Ih-Jen Su, Wenya Huang. Hepatitis B virus surface gene pre-S2mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resectionHepatology 2018; 68(3): 815 doi: 10.1002/hep.29790
16
Sanshun Zhou, Zusen Wang, Manjiang Li, Liqun Wu. Elevated Preoperative Serum CA125 Predicts Larger Tumor Diameter in Patients with Hepatocellular Carcinoma and Low AFP LevelsBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/6959637
17
Zhigui Li, Xiaoting Wu, Tianfu Wen, Chuan Li, Wen Peng. Multiple ectopic hepatocellular carcinomas in the pancreasMedicine 2017; 96(30): e6747 doi: 10.1097/MD.0000000000006747
18
Sven H. Loosen, Christoph Roderburg, Tom Luedde. Reply to: “Is osteopontin a promising prognostic biomarker for cholangiocarcinoma?”Journal of Hepatology 2018; 68(1): 206 doi: 10.1016/j.jhep.2017.08.027
19
Charles C. Vining, Phillip J. Hsu, Darryl Schuitevoerder, Nora E. Joseph, Melissa E. Hogg. Robotic Distal Pancreatectomy and Splenectomy for an Intrapancreatic Hepatocellular Carcinoma: A Case Report and Review of the LiteratureJournal of Pancreatic Cancer 2020; 6(1): 96 doi: 10.1089/pancan.2020.0009
20
Jiu Chen, Guolin Wu, Youdi Li. Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-AnalysisDisease Markers 2018; 2018: 1 doi: 10.1155/2018/8906023
21
Nan-Ee Lee, Sun Hee Kim, Dae-Yeul Yu, Eui-Jeon Woo, Myung-Il Kim, Gi-Sang Seong, Sun Min Lee, Jeong-Heon Ko, Yong-Sam Kim. Aglycosylated antibody-producing mice for aglycosylated antibody-lectin coupled immunoassay for the quantification of tumor markers (ALIQUAT)Communications Biology 2020; 3(1) doi: 10.1038/s42003-020-01363-9
22
Saurabh K. Chhonker, Divya Rawat, Raj Kumar Koiri. Protective and therapeutic effects of sildenafil and tadalafil on aflatoxin B1-induced hepatocellular carcinomaMolecular and Cellular Biochemistry 2021; 476(2): 1195 doi: 10.1007/s11010-020-03982-6
23
Hager F. Ahmed Mohammed, Lewis R. Roberts. Should AFP (or Any Biomarkers) Be Used for HCC Surveillance?Current Hepatology Reports 2017; 16(2): 137 doi: 10.1007/s11901-017-0349-7
24
Xiaonan Mao, Yan Guo, Zaiming Lu, Feng Wen, Hongyuan Liang, Wei Sun. Enhanced CT Textures Derived From Computer Mathematic Distribution Analysis Enables Arterial Enhancement Fraction Being an Imaging Biomarker Option of Hepatocellular CarcinomaFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01337
25
Jing Xie, Aihua Zhang, Xijun Wang. Metabolomic applications in hepatocellular carcinoma: toward the exploration of therapeutics and diagnosis through small moleculesRSC Advances 2017; 7(28): 17217 doi: 10.1039/C7RA00698E
26
Chyntia Olivia Maurine Jasirwan, Alessa Fahira, Lianda Siregar, Imelda Loho. The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in IndonesiaBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01365-1
27
Samy Kashkoush, Sherif Saleh, Walid Elmoghazy. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_34-1
28
Peipei Song, Qi Tang, Xiaobin Feng, Wei Tang. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinomaScandinavian Journal of Clinical and Laboratory Investigation 2016; 76(sup245): S70 doi: 10.1080/00365513.2016.1210328
29
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosisWorld Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
30
Catharine Sturgeon. Standardization of tumor markers – priorities identified through external quality assessmentScandinavian Journal of Clinical and Laboratory Investigation 2016; 76(sup245): S94 doi: 10.1080/00365513.2016.1210334
31
Samy Kashkoush, Sherif Saleh, Walid Elmoghazy. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 837 doi: 10.1007/978-94-007-7675-3_34
32
Yongzhen Liu, Xuewei Qi, Zhenzhen Zeng, Lu Wang, Jie Wang, Ting Zhang, Qiang Xu, Congle Shen, Guangde Zhou, Shaomin Yang, Xiangmei Chen, Fengmin Lu. CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic miceScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03070-8
33
Paolo Magistri, Russell Rosenblatt, Karim J. Halazun. Liver Transplantation for HCC Beyond MilanCurrent Transplantation Reports 2018; 5(4): 319 doi: 10.1007/s40472-018-0212-y
34
Ping Fang, Lijun Du, Decheng Cai. Evaluation of plasma D-dimer for the diagnosis in Chinese patients with hepatocellular carcinomaMedicine 2020; 99(12): e19461 doi: 10.1097/MD.0000000000019461
35
María Jesús Gaspar Blázquez, Jaume Trapé Pujol, Josep María Augé Fradera, Antonio Barco Sánchez, Rosa Carbonell Muñoz, Xavier Filella Pla, Antonio Fernández Suarez, Álvaro González Hernández, Antonio Martínez Peinado, Clara Pérez Barrios, Blanca Ortiz Muñoz, José Diego Santotoribio Camacho, Marta Sánchez-Carbayo, Rafael Molina Porto. Recomendaciones para la optimización del uso de marcadores tumorales de utilización frecuente. Recomendación (2018)Revista del Laboratorio Clínico 2019; 12(1): 38 doi: 10.1016/j.labcli.2018.09.002
36
Yu Sun, Qing Wang, Yu Zhang, Mengyuan Geng, Yujuan Wei, Yanrui Liu, Shanshan Liu, Robert B. Petersen, Junqiu Yue, Kun Huang, Ling Zheng. Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3pJournal of Hepatology 2020; 73(3): 603 doi: 10.1016/j.jhep.2020.03.050
37
Yang-Hsiang Lin, Meng-Han Wu, Ya-Hui Huang, Chau-Ting Yeh, Kwang-Huei Lin. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular CarcinomaCells 2020; 9(2): 262 doi: 10.3390/cells9020262
38
Dou-Sheng Bai, Chi Zhang, Ping Chen, Sheng-Jie Jin, Guo-Qing Jiang. The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-12834-1
39
Rahmi Oklu, Rahul Sheth, Hassan Albadawi, Irun Bhan, A. Fatih Sarioglu, Melissa Choz, Mahnaz Zeinali, Vikram Deshpande, Shyamala Maheswaran, Daniel A. Haber, Shannon L. Stott, Andrew X. Zhu, Lipika Goyal, Mehmet Toner, David T. Ting. Relationship between hepatocellular carcinoma circulating tumor cells and tumor volumeCancer Convergence 2018; 2(1) doi: 10.1186/s41236-018-0009-z
40
Jun Liu, Zhanzhong Ma, Yanming Liu, Liangyin Wu, Zhiwei Hou, Wenli Li. Screening of potential biomarkers in hepatitis C virus‑induced hepatocellular carcinoma using bioinformatic analysisOncology Letters 2019;  doi: 10.3892/ol.2019.10578
41
Naoto Fujiwara, Po-Hong Liu, Sai Krishna Athuluri-Divakar, Shijia Zhu, Yujin Hoshida. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 3 doi: 10.1007/978-3-030-21540-8_1
42
Chloé Sauzay, Alexandra Petit, Anne-Marie Bourgeois, Jean-Claude Barbare, Bruno Chauffert, Antoine Galmiche, Aline Houessinon. Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinomaClinica Chimica Acta 2016; 463: 39 doi: 10.1016/j.cca.2016.10.006
43
Jian Li, Tiezheng Wang, Boxun Jin, Wenlei Li, Zhenshun Wang, Haitao Zhang, Yunjun Song, Ning Li. Diagnosis accuracy of serum glypican-3 level in patients with hepatocellular carcinoma: a systematic review with meta-analysisThe International Journal of Biological Markers 2018; 33(4): 353 doi: 10.1177/1724600818784409
44
Nicolas Goossens, C. Billie Bian, Yujin Hoshida. Tailored Algorithms for Hepatocellular Carcinoma Surveillance: Is One-Size-Fits-All Strategy Outdated?Current Hepatology Reports 2017; 16(1): 64 doi: 10.1007/s11901-017-0336-z
45
Salma Abdi Mahmoud, Mohammed Mohammed Ibrahim, Ahmed Hago Musa, Yuhong Huang, Jun Zhang, Jingwen Wang, Yuanyi Wei, Li Wang, Shunting Zhou, Boyi Xin, Wei Xuan, Jianwu Tang. Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelinJournal of Cell Communication and Signaling 2018; 12(3): 603 doi: 10.1007/s12079-017-0411-9
46
Gian Paolo Caviglia, Davide Giuseppe Ribaldone, Maria Lorena Abate, Alessia Ciancio, Rinaldo Pellicano, Antonina Smedile, Giorgio Maria Saracco. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysisScandinavian Journal of Gastroenterology 2018; 53(6): 734 doi: 10.1080/00365521.2018.1459824
47
Alejandra V. Contreras, Benjamin Cocom-Chan, Georgina Hernandez-Montes, Tobias Portillo-Bobadilla, Osbaldo Resendis-Antonio. Host-Microbiome Interaction and Cancer: Potential Application in Precision MedicineFrontiers in Physiology 2016; 7 doi: 10.3389/fphys.2016.00606
48
Dan G. Duda, Simona O. Dima, Dana Cucu, Andrei Sorop, Sebastian Klein, Marek Ancukiewicz, Shuji Kitahara, Speranta Iacob, Nicolae Bacalbasa, Dana Tomescu, Vlad Herlea, Cristiana Tanase, Adina Croitoru, Irinel Popescu. Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma PatientsCancers 2020; 12(5): 1275 doi: 10.3390/cancers12051275
49
Dincer Ozgor, Emrah Otan. HCC and Tumor Biomarkers: Does One Size Fits All?Journal of Gastrointestinal Cancer 2020; 51(4): 1122 doi: 10.1007/s12029-020-00485-x
50
Fumiko Chino, Sarah Jo Stephens, Steve S. Choi, Daniele Marin, Charles Y. Kim, Michael A. Morse, Devon J. Godfrey, Brian G. Czito, Christopher G. Willett, Manisha Palta. The role of external beam radiotherapy in the treatment of hepatocellular cancerCancer 2018; 124(17): 3476 doi: 10.1002/cncr.31334
51
Chang-Liang Luo, Yuan Rong, Hao Chen, Wu-Wen Zhang, Long Wu, Diao Wei, Xiu-Qi Wei, Lie-Jun Mei, Fu-Bing Wang. A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular CarcinomaTechnology in Cancer Research & Treatment 2019; 18: 153303381984663 doi: 10.1177/1533033819846632
52
Roberta D'Ambrosio, Massimo Colombo. Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression?Liver International 2016; 36(6): 783 doi: 10.1111/liv.13106
53
H Elalfy, T Besheer, MA El-Maksoud, K Farid, M Elegezy, AM El Nakib, MA El-Aziz, AA El-Khalek, A El-Morsy, A Elmokadem, AZ Elsamanoudy, M El-Bendary. Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolizationBritish Journal of Biomedical Science 2018; 75(4): 187 doi: 10.1080/09674845.2018.1494769
54
Lijun Wan, Li Guo, Youwen Hu, Hongyan Huang, Moran Zhang, Kedong Xu, Gejirifu De, Fengfei Zheng, Zhengqiang Wu, Chungen Hu, Zhili Wen. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancerClinical Biochemistry 2021; 89: 44 doi: 10.1016/j.clinbiochem.2020.12.005
55
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsOncotarget 2017; 8(8): 14192 doi: 10.18632/oncotarget.13929
56
Vijay Pandyarajan, Rajalakshmi Govalan, Ju Dong Yang. Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2021; 22(2): 479 doi: 10.3390/ijms22020479
57
Alessandro Loglio, Massimo Iavarone, Floriana Facchetti, Dhanai Di Paolo, Riccardo Perbellini, Giovanna Lunghi, Ferruccio Ceriotti, Claudio Galli, Maria T. Sandri, Mauro Viganò, Angelo Sangiovanni, Massimo Colombo, Pietro Lampertico. The combination of PIVKA‐II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long‐term oral therapyLiver International 2020; 40(8): 1987 doi: 10.1111/liv.14475
58
Yoshimi Haga, Motohide Uemura, Satoko Baba, Kentaro Inamura, Kengo Takeuchi, Norio Nonomura, Koji Ueda. Identification of Multisialylated LacdiNAc Structures as Highly Prostate Cancer Specific Glycan Signatures on PSAAnalytical Chemistry 2019; 91(3): 2247 doi: 10.1021/acs.analchem.8b04829
59
Nan Zhang, Jiajia Gu, Li Yin, Jing Wu, Ming-yu Du, Kai Ding, Teng Huang, Xia He. Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER databaseOncotarget 2016; 7(49): 81389 doi: 10.18632/oncotarget.13232
60
Kim M. Olthoff, David S. Goldberg. The MoRAL Path Beyond MilanAnnals of Surgery 2016; 263(5): 851 doi: 10.1097/SLA.0000000000001679
61
Wasila Mansouri, Samuel B. Fordyce, Matthew Wu, David Jones, Douglas Cohn, Qishan Lin, Paul Feustel, Tanuj Sharma, James A. Bennett, Thomas T. Andersen. Efficacy and tolerability of AFPep, a cyclic peptide with anti-breast cancer propertiesToxicology and Applied Pharmacology 2018; 345: 10 doi: 10.1016/j.taap.2018.03.004
62
Naoto Fujiwara, Scott L. Friedman, Nicolas Goossens, Yujin Hoshida. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicineJournal of Hepatology 2018; 68(3): 526 doi: 10.1016/j.jhep.2017.09.016
63
Wai Yeow Lee, Maulana Bachtiar, Cheryl C. S. Choo, Caroline G. Lee. Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analyticsBiological Reviews 2019; 94(2): 353 doi: 10.1111/brv.12457